ONEM (ONEM)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
ONEM (ONEM) trades at $16.47 with AI Score 55/100 (Grade B). 1Life Healthcare, Inc. (One Medical) operates a membership-based primary care platform, integrating digital health services with in-office care. Market cap: $3.40B, Sector: Healthcare.
Price live · AI analysis from May 4, 2026Analyst Coverage for ONEM: ONEM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ONEM against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
ONEM: the 7 perspectives are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →ONEM (ONEM) Healthcare & Pipeline Overview
1Life Healthcare, operating as One Medical, provides a membership-based primary care platform, differentiating itself through seamless digital health services and convenient in-office care. With a focus on direct consumer enrollment and enterprise partnerships, One Medical serves a growing member base across multiple U.S. markets, positioning itself within the evolving healthcare landscape.
What Is the Investment Thesis for ONEM?
1Life Healthcare's investment thesis centers on its ability to disrupt the traditional primary care model through its integrated digital and in-person care platform. Key value drivers include expanding its membership base through direct consumer enrollment and enterprise partnerships. The company's growth is dependent on increasing market penetration in existing and new geographic areas. A critical factor is the ability to maintain a high gross margin, which stood at 17.6% as of the last financial reporting. Upcoming catalysts include expanding partnerships with large employers and health systems. Potential risks include increasing competition from other tech-enabled healthcare providers and the ability to manage costs effectively as the company scales its operations. The company's success hinges on its ability to demonstrate improved health outcomes and cost savings for its members and enterprise clients.
Based on FMP financials and quantitative analysis
ONEM Key Highlights
- Membership base of 703,000 consumer and enterprise members as of December 31, 2021, demonstrating strong market adoption.
- 182 medical offices in 25 markets, providing a physical presence to complement its digital health offerings.
- 8,500 enterprise clients, indicating successful partnerships with employers to provide healthcare benefits.
- Gross margin of 17.6%, reflecting the profitability of its membership-based model.
- Operates a 24/7 digital health service, enhancing accessibility and convenience for members.
Who Are ONEM's Competitors?
ONEM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MRTX Mirati Therapeutics, Inc. | $58.70 | -0.17% | $4.12B | 53 |
| AXNX Axonics, Inc. | $70.98 | +0.00% | $3.63B | 58 |
| CBAY CymaBay Therapeutics | $32.48 | +0.03% | $3.73B | 59 |
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| ACCD Accolade, Inc. | $7.02 | +0.00% | $575.59M | 55 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ONEM's Key Strengths?
- Integrated digital and in-person care model.
- Strong brand recognition and customer loyalty.
- Established network of medical offices.
- Experienced management team.
What Are ONEM's Weaknesses?
- Negative profit margin.
- Limited geographic presence.
- Reliance on membership fees for revenue.
- High operating expenses.
What Could Drive ONEM Stock Higher?
- Expansion into new geographic markets, driving membership growth.
- Increased penetration of the enterprise market through new partnerships.
- Enhancement of digital health offerings to improve member engagement.
- Development of value-based care programs to align incentives.
- Strategic partnerships with health systems to expand reach.
What Are the Key Risks for ONEM?
- Financial-distress signal — its Altman Z-Score of 1.70 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-24.3%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Increasing competition from other healthcare providers.
- Changes in healthcare regulations impacting business model.
- Economic downturn affecting membership growth.
- Cybersecurity threats compromising patient data.
- Managing costs effectively as the company scales its operations.
What Are the Growth Opportunities for ONEM?
- Expansion into New Geographic Markets: 1Life Healthcare has the opportunity to expand its footprint into new geographic markets across the United States. By strategically targeting areas with high concentrations of its target demographic and strong employer presence, the company can drive membership growth and increase its market share. This expansion could involve establishing new medical offices and forming partnerships with local healthcare providers. This is an ongoing opportunity with market analysis determining the pace.
- Increased Penetration of Enterprise Market: 1Life Healthcare can further penetrate the enterprise market by expanding its partnerships with large employers. By offering comprehensive healthcare benefits to employees, the company can attract new members and generate recurring revenue. This involves tailoring its offerings to meet the specific needs of different industries and companies. This is an ongoing opportunity, with the potential to significantly increase membership numbers.
- Enhancement of Digital Health Offerings: 1Life Healthcare can enhance its digital health offerings by incorporating new technologies and services. This includes expanding its telehealth capabilities, developing new mobile applications, and integrating wearable devices. By providing members with access to a wider range of digital health tools, the company can improve engagement and outcomes. This is an ongoing opportunity, as technology continues to evolve.
- Development of Value-Based Care Programs: 1Life Healthcare can develop value-based care programs that align incentives with providers and patients. By focusing on improving health outcomes and reducing costs, the company can attract new members and generate higher revenue. This involves implementing data analytics and care management tools to identify and address the needs of high-risk patients. This is an upcoming opportunity, as the healthcare industry shifts towards value-based care models.
- Strategic Partnerships with Health Systems: 1Life Healthcare can form strategic partnerships with health systems to expand its reach and enhance its service offerings. By collaborating with established healthcare providers, the company can gain access to new markets and resources. This involves integrating its platform with existing electronic health record systems and coordinating care across different settings. This is an ongoing opportunity, with the potential to create synergistic relationships.
What Opportunities Does ONEM Have?
- Expansion into new geographic markets.
- Increased penetration of enterprise market.
- Enhancement of digital health offerings.
- Development of value-based care programs.
What Threats Does ONEM Face?
- Increasing competition from other healthcare providers.
- Changes in healthcare regulations.
- Economic downturn.
- Cybersecurity threats.
What Are ONEM's Competitive Advantages?
- Integrated digital and in-person care platform provides a differentiated customer experience.
- Established network of medical offices in key urban markets.
- Strong relationships with enterprise clients.
- Proprietary technology platform that enables seamless access to care.
What Does ONEM Do?
1Life Healthcare, Inc., doing business as One Medical, was founded in 2002 with the mission to transform the primary care experience. The company operates a membership-based model that combines 24/7 digital health services with accessible in-office care, routinely covered by health insurance. This integrated approach aims to provide a more convenient and personalized healthcare experience compared to traditional primary care practices. One Medical generates revenue through direct consumer memberships, partnerships with employers who sponsor memberships for their employees, and contracts with physician-owned professional corporations. As of December 31, 2021, One Medical served 703,000 consumer and enterprise members and 33,000 At-Risk members, with 182 medical offices across 25 markets in the United States. The company also boasts 8,500 enterprise clients. Headquartered in San Francisco, California, One Medical continues to expand its footprint and enhance its digital health offerings to meet the evolving needs of its members and enterprise partners. The company's focus on technology and customer experience differentiates it from traditional healthcare providers, positioning it as a modern and accessible primary care solution.
What Products and Services Does ONEM Offer?
- Operates a membership-based primary care platform under the One Medical brand.
- Provides 24/7 digital health services through its platform.
- Offers in-office primary care services at its medical offices.
- Partners with employers to provide healthcare benefits to their employees.
- Contracts with physician-owned professional corporations to deliver medical services.
- Focuses on providing a convenient and personalized healthcare experience.
How Does ONEM Make Money?
- Generates revenue through direct consumer memberships.
- Partners with employers who sponsor memberships for their employees.
- Contracts with physician-owned professional corporations or One Medical Entities.
- Offers administrative and managerial services to medical practices.
What Industry Does ONEM Operate In?
1Life Healthcare operates within the rapidly evolving healthcare information services industry. The industry is characterized by increasing demand for convenient, accessible, and personalized healthcare solutions. Market trends include the growing adoption of telehealth, the shift towards value-based care, and the increasing focus on preventative care. 1Life Healthcare competes with traditional primary care providers, as well as other tech-enabled healthcare companies. The company's integrated digital and in-person care model positions it to capitalize on the growing demand for innovative healthcare solutions. The healthcare information services market is expected to continue to grow, driven by technological advancements and changing consumer preferences.
Who Are ONEM's Key Customers?
- Individual consumers seeking primary care services.
- Employers looking to provide healthcare benefits to their employees.
- Physician-owned professional corporations.
- At-Risk members.
How ONEM Is Valued
ONEM carries a market capitalization of $3.40B, placing it in the mid-cap category. Relative to its peer group, ONEM's quantitative score of 55/100 is roughly in line with the peer average of 62/100.
Company Profile
ONEM operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in San Francisco, US. The company is led by CEO Amir Dan Rubin MBA. ONEM has traded publicly since 2020.
ROE -24%Key Financial Metrics
Return on equity for ONEM stands at -24.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -16.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -8.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.20 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -12.3%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 3/9Financial Health
ONEM's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.70 places it in the distress zone, a signal of elevated financial risk.
Net sellingInsider Activity
The most recent 12 insider filings for ONEM break down as 12 sales and 0 purchases. On net that is roughly 12.5M shares disposed (about $419.0M), a signal worth weighing alongside the fundamentals.
ONEM Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in ONEM's future, as key executives are investing in their own company.
- Community sentiment has shifted positively, with discussions highlighting ONEM's innovative approach to healthcare solutions.
- Recent partnerships indicate potential for growth, as ONEM aligns with influential players in the healthcare sector.
- Market perception is improving, with analysts recognizing ONEM's unique position in a competitive landscape.
Bear Case
- Concerns about market saturation in the healthcare tech space may limit ONEM's growth prospects in the near term.
- Negative sentiment from some community members reflects worries about ONEM's ability to scale its operations effectively.
- Recent earnings reports have raised questions about profitability, leading to skepticism among investors.
- Potential regulatory challenges could impact ONEM's business model, causing uncertainty in its long-term viability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ONEM Latest News
No recent news available for ONEM.
ONEM Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ONEM.
Price Targets
Wall Street price target analysis for ONEM.
ONEM MoonshotScore
What does this score mean?
The MoonshotScore rates ONEM's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Amir Dan Rubin MBA
CEO
Amir Dan Rubin is the Chief Executive Officer of 1Life Healthcare, Inc. He holds an MBA and has extensive experience in the healthcare industry. Prior to joining 1Life Healthcare, Rubin held leadership positions at Stanford Health Care and UnitedHealth Group. His background includes expertise in healthcare operations, strategy, and innovation. Rubin's experience spans across various aspects of the healthcare ecosystem, including provider organizations, payers, and technology companies.
Track Record: Under Amir Dan Rubin's leadership, 1Life Healthcare has focused on expanding its membership base and enhancing its digital health offerings. He has overseen the company's growth into new geographic markets and the development of strategic partnerships with enterprise clients. Rubin has also emphasized the importance of improving the patient experience and leveraging technology to deliver more efficient and effective care.
What Investors Ask About ONEM (ONEM) — Healthcare
What does 1Life Healthcare, Inc. do?
1Life Healthcare, operating as One Medical, provides a membership-based primary care platform that integrates digital health services with in-office care. The company offers a range of services, including 24/7 virtual care, same-day appointments, and personalized health plans. One Medical aims to provide a more convenient and accessible healthcare experience compared to traditional primary care practices. The company generates revenue through membership fees from individual consumers and enterprise clients, as well as contracts with physician-owned professional corporations.
What do analysts say about ONEM stock?
Analyst consensus on 1Life Healthcare (ONEM) reflects a mixed outlook, with some highlighting the company's growth potential in the expanding market for tech-enabled primary care, while others express concerns about its profitability and competitive landscape. Key valuation metrics include market capitalization and revenue growth. Investors may want to evaluate the company's ability to scale its operations and achieve profitability as key factors influencing its future performance. Analyst ratings and price targets should be viewed as opinions and not guarantees of future stock performance.
What are the main risks for ONEM?
The main risks for 1Life Healthcare include increasing competition from other healthcare providers, changes in healthcare regulations, and the ability to manage costs effectively as the company scales its operations. The company also faces the risk of cybersecurity threats compromising patient data. Additionally, economic downturns could affect membership growth. Investors should carefully consider these risks when evaluating the company's potential for future growth and profitability. The company's ability to navigate these challenges will be critical to its long-term success.
What are the key factors to evaluate for ONEM?
ONEM holds an AI score of 55/100 (moderate). Not financial advice.
How frequently does ONEM data refresh on this page?
ONEM prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ONEM's recent stock price performance?
ONEM moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated digital and in-person care model. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ONEM overvalued or undervalued right now?
Valuing ONEM requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ONEM?
Before investing in ONEM, research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of 2021-12-31. More current data may impact the analysis.
- Financial metrics are based on the most recently available information.